Abstract:Objective To investigate the expression of metastasis-associated in colon cancer 1 (MACC1) protein in gastric cancerous tissue and adjacent noncancerous tissue and its relationships with the clinical pathological factors and the cancerous inhibitor of protein phosphatase 2A (CIP2A) protein expression, and evaluate the prognosis so as to provide the train of thought for the treatment of gastric cancer. Methods RT-PCR was used to assay the expression of MACC1 protein in gastric cancerous tissue and adjacent noncance-rous tissue. Immunohistochemical assay was used to detect the expressions of MACC1 and CIP2A proteins in gastric cancerous tissue and adjacent noncancerous tissue of 30 cases. The relationships of the expression of MACC1 protein with clinical pathological factors and CIP2A protein were analyzed. Results The positive rate of MACC1 in the gastric cancerous tissue and the adjacent noncancerous tissue was 16.7% and 76.7% respectively, the difference was statistically significant. The positive rate of CIP2A protein expression in the gastric cancerous tissue and the adjacent noncancerous tissue was 23.3% and 73.3% respectively with significant difference. The expression of MACC1 protein was not significantly different between the patients with different gender, different age or different histological types of gastric cancers. However, the patients with different depth of tumor invasion, different degree of cancer differentiation, different degree of lymph node metastasis and different clinical stage had significant differences in MACC1 expression. MACC1 and CIP2A protein expressions were positively correlated. Conclusions MACC1 protein expression is positively correlated with CIP2A protein expression, combined detection of both can help to determine the prognosis of the patients.